Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 2008

View Archived Issues

XOMA-052 shows antiarthritic effects in murine CIA model

New class of amyloid-inhibiting agents described

Combination of IMC-11F8 and mFOLFOX-6 appears well tolerated in colorectal cancer

New data on axitinib in metastatic cancers presented

Bristol-Myers Squibb's acquisition of Kosan Biosciences complete

Positive E.U. opinion issued to extend use of bosentan in pulmonary hypertension

CHMP issues positive opinion for Cymbalta in generalized anxiety disorder

CHMP issues positive opinion for UCB's Vimpat in epilepsy

CHMP recommends approval of Abstral for breakthrough cancer pain

Lux Biosciences completes enrollment in LUMINATE clinical trial program for Luveniq

Merck & Co. initiates phase IIb clinical trial of SurModics' I-vation intravitreal implant

FDA issues complete response to Merck & Co.'s sBLA for Gardasil in women ages 27 to 45

Results from preclinical studies of oral CP-4126 support advancement into clinical studies

Sun Pharmaceutical exercises options to acquire shares of controlling shareholders of Taro

Medicago reports additional results from preclinical study of H5N1 VLP vaccine

Hisamitsu files for approval in Japan of HFT-290 in cancer pain

Recent patents disclose novel antiinfective agents

ACR-325 advances into phase II PoC studies in PD, bipolar disorder

PN-277 shows benefit in experimental Parkinson's disease

SciClone and Sigma-Tau present update on phase III trial of Zadaxin in HCV

FDA accepts for priority review Eisai's sBLA for Ontak in CTCL

ImClone initiates enrollment in phase I clinical trial of IMC-A12 plus temsirolimus

New agents for endocrine-associated disorders disclosed in recent patents

Compugen discovers biomarkers for early detection of kidney toxicity

CHMP issues positive opinion for Tibotec's etravirine in HIV infection

Novel agents for psychiatric disorders reported in recent patent literature

German approval for Oralair Grasses

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...